TRxADE HEALTH Statistics Share Statistics TRxADE HEALTH has 1.75M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 1.75M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 0.05% Shares Floating 734.54K Failed to Deliver (FTD) Shares 1,351 FTD / Avg. Volume 2.19%
Short Selling Information The latest short interest is 18.22K, so 0% of the outstanding
shares have been sold short.
Short Interest 18.22K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.2
Valuation Ratios The PE ratio is 2.58 and the forward
PE ratio is null.
TRxADE HEALTH's PEG ratio is
-0.02.
PE Ratio 2.58 Forward PE n/a PS Ratio 170.94 Forward PS n/a PB Ratio 0.3 P/FCF Ratio -1.76 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation TRxADE HEALTH has an Enterprise Value (EV) of 26.17M.
EV / Sales 191.5 EV / EBITDA -1.39 EV / EBIT -1.97 EV / FCF -1.97
Financial Position The company has a current ratio of 0.8,
with a Debt / Equity ratio of 0.04.
Current Ratio 0.8 Quick Ratio 0.8 Debt / Equity 0.04 Debt / EBITDA -0.17 Debt / FCF -0.23 Interest Coverage 14.06
Financial Efficiency Return on Equity is 11.47% and Return on Invested Capital is -17.86%.
Return on Equity 11.47% Return on Assets 8.65% Return on Invested Capital -17.86% Revenue Per Employee $17.08K Profits Per Employee $1.13M Employee Count 8 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 534.4K Effective Tax Rate 5.57%
Stock Price Statistics The stock price has increased by -4.05% in the
last 52 weeks. The beta is 2.17, so TRxADE HEALTH's
price volatility has been higher than the market average.
Beta 2.17 52-Week Price Change -4.05% 50-Day Moving Average 7.29 200-Day Moving Average 8.98 Relative Strength Index (RSI) 42.89 Average Volume (20 Days) 61,782
Income Statement In the last 12 months, TRxADE HEALTH had revenue of 136.64K
and earned 9.07M
in profits. Earnings per share was 2.69.
Revenue 136.64K Gross Profit 6K Operating Income -18.78M Net Income 9.07M EBITDA -18.78M EBIT n/a Earnings Per Share (EPS) 2.69
Full Income Statement Balance Sheet The company has 308.1K in cash and 3.12M in
debt, giving a net cash position of -2.81M.
Cash & Cash Equivalents 308.1K Total Debt 3.12M Net Cash -2.81M Retained Earnings -39.04M Total Assets 104.29M Working Capital -6.83M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -13.29M
and capital expenditures 0, giving a free cash flow of -13.29M.
Operating Cash Flow -13.29M Capital Expenditures n/a Free Cash Flow -13.29M FCF Per Share -3.94
Full Cash Flow Statement Margins Gross margin is 4.39%, with operating and profit margins of -13743.02% and 6634.66%.
Gross Margin 4.39% Operating Margin -13743.02% Pretax Margin 7025.75% Profit Margin 6634.66% EBITDA Margin -13743.02% EBIT Margin -13743.02% FCF Margin -9723.27%
Dividends & Yields MEDS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 38.81% FCF Yield -56.88%
Dividend Details Analyst Forecast Currently there are no analyst rating for MEDS.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 37.63 Graham Upside 395.78%
Stock Splits The last stock split was on Jun 22, 2023. It was a
backward
split with a ratio of 1:15.
Last Split Date Jun 22, 2023 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -0.21 Piotroski F-Score 2
